Lincoln Joy, Garg Vidu
Center for Cardiovascular and Pulmonary Research and The Heart Center at Nationwide Children's Hospital.
Circ J. 2014;78(8):1801-7. doi: 10.1253/circj.cj-14-0510. Epub 2014 Jul 7.
Valvular heart disease occurs as either a congenital or acquired condition and advances in medical care have resulted in valve disease becoming increasingly prevalent. Unfortunately, treatments remain inadequate because of our limited understanding of the genetic and molecular etiology of diseases affecting the heart valves. Therefore, surgical repair or replacement remains the most effective option, which comes with additional complications and no guarantee of life-long success. Over the past decade, there have been significant advances in our understanding of cardiac valve development and, not surprisingly, mutations in these developmental genes have been identified in humans with congenital valve malformations. Concurrently, there has been a greater realization that acquired valve disease is not simply a degenerative process. Molecular investigation of acquired valve disease has identified that numerous signaling pathways critical for normal valve development are re-expressed in diseased valves. This review will discuss recent advances in our understanding of the development of the heart valves, as well as the implications of these findings on the genetics of congenital and acquired valvular heart disease.
心脏瓣膜病可作为先天性或后天性疾病出现,医疗水平的进步导致瓣膜病越来越普遍。不幸的是,由于我们对影响心脏瓣膜疾病的遗传和分子病因了解有限,治疗方法仍然不足。因此,手术修复或置换仍然是最有效的选择,但会带来额外的并发症,且不能保证终身成功。在过去十年中,我们对心脏瓣膜发育的理解有了重大进展,不出所料,在患有先天性瓣膜畸形的人类中发现了这些发育基因的突变。同时,人们越来越认识到后天性瓣膜病不仅仅是一个退行性过程。对后天性瓣膜病的分子研究表明,许多对正常瓣膜发育至关重要的信号通路在患病瓣膜中重新表达。本综述将讨论我们对心脏瓣膜发育理解的最新进展,以及这些发现对先天性和后天性心脏瓣膜病遗传学的影响。